Subject(s)
Desensitization, Immunologic , Humans , Surveys and Questionnaires , Desensitization, Immunologic/methods , Female , Male , Administration, Oral , Allergens/immunology , Allergens/administration & dosage , Adult , Patient Reported Outcome Measures , Child , Adolescent , Food Hypersensitivity/diagnosis , Middle AgedABSTRACT
Oral immunotherapy (OIT) is an accessible procedure for practicing allergy/immunology providers, yet rigorous safety standards are limited in the clinical setting. By exploring the transition from research to clinical practice OIT, we review relevant safety considerations necessary for the clinical provider. We offer a perspective on clinical benefits and considerations at the individual, collaboration, and policy levels from the vantage of a large academic OIT program, and we propose several practical start-up checklists and clerical considerations for practicing providers. Awareness of the local population and front-end planning is necessary to improve the accessibility of this procedure in clinical practice among racial and socioeconomic minority populations. Sharing and merging OIT protocols, procedural methods, and electronic medical record order sets may increase harmonization among OIT-providing institutions and further our abilities to pool safety and outcomes data, ultimately enhancing the safety and efficacy of clinical OIT.